Role as Principal Investigator Sample Clauses

Role as Principal Investigator. Investigator shall serve as the principal investigator for the Study at Institution, and shall personally conduct and/or supervise all aspects of the Study, including reviewing, signing, and dating Idorsia supplied case report forms which record all of the Protocol-required information to be reported to Idorsia for each Subject (defined below) ("CRFs"). Prior to commencing the Study, Investigator shall have read and understood the information contained in the Investigator's brochure. Institution or Investigator shall submit the following to Idorsia before conducting the Study and shall retain copies for Regulatory Authority review: (i) Investigator's current curriculum vitae, (ii) documentation of all IRB/IEC approvals in accordance with Section 1.2.1 (IRB/IEC review), and (iii) a copy of the IRB/IEC- approved ICF (as defined below) to be used in the Study. Investigator shall use his/her best efforts to recruit Study Subjects (as defined below), who are in Investigator's reasonable judgment, likely to be eligible and sufficiently reliable to complete the entire Study.
Sample 1See All (4)
AutoNDA by SimpleDocs
Role as Principal Investigator. Investigator shall serve as the principal investigator for the Study at Institution, and shall person- ally conduct and/or supervise all aspects of the Study, including reviewing, signing, and dating Idorsia supplied case report forms which record all of the Protocol-re- quired information to be reported to Idorsia for each Subject (defined below) ("CRFs"). Prior to commencing the Study, Investiga- tor shall have read and understood the in- formation contained in the Investigator's brochure. Institution or Investigator shall submit the following to Idorsia before con- ducting the Study and shall retain copies for Regulatory Authority review: (i) Investi- gator's current curriculum vitae, (ii) docu- mentation of all IRB/IEC approvals in ac- cordance with Section 1.2.1 (IRB/IEC re- view), and (iii) a copy of the IRB/IEC-ap- proved ICF (as defined below) to be used in the Study. Investigator shall use his/her best efforts to recruit Study Subjects (as defined below), who are in Investigator's reasonable judgment, likely to be eligible and sufficiently reliable to complete the en- tire Study.
Sample 1Sample 2
Role as Principal Investigator. Investigator shall serve as the principal investigator for the Study at Institution, and shall personally conduct and/or supervise all aspects of the Study, including reviewing, signing, and dating Idorsia supplied case report forms which record all of the Protocol-required information to be reported to Idorsia for each Subject (defined below) ("CRFs"). Prior to commencing the Study, Investigator shall have read and understood the information contained in the Investigator's brochure, as submitted by Idorsia. Institution or Investigator shall submit Investigator’s current curriculum vitae to Idorsia before 1.5.1
Sample 1
Role as Principal Investigator. Investigator shall serve as the principal investigator for the Study at Institution and shall personally conduct and/or supervise all aspects of the Study, including reviewing, signing, and dating Idorsia supplied case report forms which record all of the Protocol-required information to be reported to Idorsia for each Subject (defined below) ("CRFs"). Prior to commencing the Study, Investiga- tor shall have read and understood the in- formation contained in the Investigator's brochure. Institution or Investigator shall retain the following copies for Regulatory Authority review before conducting the Study: (i) Investigator's current curriculum vitae, (ii) documentation of all IRB/IEC ap- provals in accordance with Section 1.2.
Sample 1
Role as Principal Investigator. Investigator shall serve as the principal investigator for the Study at Institution, and shall personally conduct and/or supervise all aspects of the Study, including reviewing, signing, and dating Idorsia supplied case report forms which record all of the Protocol-required information to be reported to Idorsia for each Subject (defined below) ("CRFs"). Prior to commencing the Study, Investigator shall have read and understood the information contained in the Investigator's brochure. Investigator shall submit to Idorsia before conducting the Study Investigator's current curriculum vitae and shall retain the following copies of documents for Regulatory Authority review: (i) documentation of all IRB/IEC approvals in accordance with Section 1.2.1 (IRB/IEC review), and (ii) a copy of the IRB/IEC- approved ICF (as defined below) to be used in the Study, (ii) documentation of all IRB/IEC approvals in accordance with Section 1.2.1 (IRB/IEC review), and (iii) a copy of the IRB/IEC-approved ICF (as defined below) to be used in the Study. Investigator shall use his/her best efforts to recruit Study Subjects (as defined below), who are in Investigator's reasonable judgment, likely to be eligible and sufficiently reliable to complete the entire Study.
Sample 1
Role as Principal Investigator. Investigator shall serve as the principal investigator for the Study at Institution, and shall personally conduct and/or supervise
Sample 1

Related to Role as Principal Investigator

  • Principal Investigator The Research will be supervised by __________________ ("Principal Investigator"). If for any reason the individual is unable to continue to serve as Principal Investigator and a successor acceptable to both the University and the Sponsor is not available, this agreement shall be terminated as provided in Article 9. The Principal Investigator may work with others at the University (“Associates”) in conducting the Research.

  • INITIAL INVESTMENT The Advisor has contributed to the Company $200,000 in exchange for 20,000 Equity Shares (the "Initial Investment"). The Advisor may not sell these shares while the Advisory Agreement is in effect, although the Advisor may transfer such shares to Affiliates. The restrictions included above shall not apply to any Equity Shares, other than the Equity Shares acquired through the Initial Investment, acquired by the Advisor or its Affiliates. The Advisor shall not vote any Equity Shares it now owns, or hereafter acquires, in any vote for the removal of Directors or any vote regarding the approval or termination of any contract with the Advisor or any of its Affiliates.

  • Legal Investment On the Closing Date, the sale and issuance of the Shares and the proposed issuance of the Conversion Shares shall be legally permitted by all laws and regulations to which Purchasers and the Company are subject.

  • Investigator Where a difference arises between the parties relating to the dismissal, discipline or suspension of an employee, or to the interpretation, application, operation or alleged violation of this agreement, including any questions as to whether a matter is arbitrable, during the term of the collective agreement, an arbitrator agreed to by the parties shall, at the request of either party: (a) investigate the difference; (b) define the issue in the difference; and (c) make written recommendations to resolve the difference within five days of the date of receipt of the request and for those five days from that date time does not run in respect of the grievance procedure. The parties agree that this procedure will not be invoked until the grievance procedure has been completed.

  • Investor Relations Firm Promptly after the execution of a definitive agreement for a Business Combination, the Company shall retain an investor relations firm with the expertise necessary to assist the Company both before and after the consummation of the Business Combination for a term to be agreed upon by the Company and the Representative.

  • Submitting Investigator An investigator who submitted a genomic dataset to an NIH designated data repository (e.g., dbGaP).

  • Technology Research Analyst Job# 1810 General Characteristics

  • Citizenship Certificates; Non-citizen Assignees (a) If any Group Member is or becomes subject to any federal, state or local law or regulation that the General Partner determines would create a substantial risk of cancellation or forfeiture of any property in which the Group Member has an interest based on the nationality, citizenship or other related status of a Limited Partner, the General Partner may request any Limited Partner to furnish to the General Partner, within 30 days after receipt of such request, an executed Citizenship Certification or such other information concerning his nationality, citizenship or other related status (or, if the Limited Partner is a nominee holding for the account of another Person, the nationality, citizenship or other related status of such Person) as the General Partner may request. If a Limited Partner fails to furnish to the General Partner within the aforementioned 30-day period such Citizenship Certification or other requested information or if upon receipt of such Citizenship Certification or other requested information the General Partner determines that a Limited Partner is not an Eligible Citizen, the Limited Partner Interests owned by such Limited Partner shall be subject to redemption in accordance with the provisions of Section 4.10. In addition, the General Partner may require that the status of any such Limited Partner be changed to that of a Non-citizen Assignee and, thereupon, the General Partner shall be substituted for such Non-citizen Assignee as the Limited Partner in respect of the Non-citizen Assignee’s Limited Partner Interests. (b) The General Partner shall, in exercising voting rights in respect of Limited Partner Interests held by it on behalf of Non-citizen Assignees, distribute the votes in the same ratios as the votes of Partners (including the General Partner) in respect of Limited Partner Interests other than those of Non-citizen Assignees are cast, either for, against or abstaining as to the matter. (c) Upon dissolution of the Partnership, a Non-citizen Assignee shall have no right to receive a distribution in kind pursuant to Section 12.4 but shall be entitled to the cash equivalent thereof, and the Partnership shall provide cash in exchange for an assignment of the Non-citizen Assignee’s share of any distribution in kind. Such payment and assignment shall be treated for Partnership purposes as a purchase by the Partnership from the Non-citizen Assignee of his Limited Partner Interest (representing his right to receive his share of such distribution in kind). (d) At any time after he can and does certify that he has become an Eligible Citizen, a Non-citizen Assignee may, upon application to the General Partner, request that with respect to any Limited Partner Interests of such Non-citizen Assignee not redeemed pursuant to Section 4.10, such Non-citizen Assignee be admitted as a Limited Partner, and upon approval of the General Partner, such Non-citizen Assignee shall be admitted as a Limited Partner and shall no longer constitute a Non-citizen Assignee and the General Partner shall cease to be deemed to be the Limited Partner in respect of the Non-citizen Assignee’s Limited Partner Interests.

  • Potential Investor’s Representative The Potential Investor, if any, has appointed the Potential Investor’s Representative, if any, identified above, as Potential Investor’s broker or other intermediary with respect to the purchase of the Property. The Potential Investor agrees to pay out of Potential Investor’s own funds all brokerage fees, finder's fees or any other compensation claimed by the Potential Investor’s Representative or any broker or intermediary other than JLL in connection with Potential Investor’s interest in or proposed or actual purchase of the Property or any interest therein. The Potential Investor’s Representative, if any, by signing below, agrees to be bound by all the terms and conditions of this Agreement whether stated as obligations of the Potential Investor or a Related Party under the terms and conditions of this Agreement. The Potential Investor’s Representative, if any, further agrees by signing below that it will not look to the Owner, JLL or any Owner/JLL Related Party for any brokerage commissions, finder's fee or any other compensation claimed in connection with the sale of the Property or any interest therein to the Potential Investor or any other party (whether or not consummated for any reason). The Potential Investor's Representative, if any, by its signature hereto agrees herewith that its authorization to act in any capacity with respect to the purchase of the Property is limited to representing the Potential Investor and agrees that it will not discuss or exchange any information regarding the Property with any party other than the Potential Investor. Potential investor and Potential Investor’s Representative, if any, by its signature hereto agree to hold JLL and Owner, its officers, directors, partners, employees, agents, representatives, and any of their affiliates, beneficiaries, successors, and assigns harmless from, and shall indemnify and defend them against any and all fines, losses, damages suites, claims actions, demands, liabilities, costs and expenses (including court costs and attorney’s fees) of any kind, nature or character (collectively, the “Claims”), in connection with, related to, resulting from or arising or alleged to have arisen in connection with the Potential Investor’s Representative’s actions.

  • Institution and Investigator acknowledge and agree that its, his or her judgment with respect to its, his or her advice to and care of each Subject is not and shall not be affected by the compensation Institution and/or Investigator receive in accordance with the Study.

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!